Skip to main content
Clinical Trials/NCT00631540
NCT00631540CompletedNot Applicable

REFORM Clinical Study: Treatment of Renal Artery Stenosis With the Formula Balloon-Expandable Stent

Cook Group Incorporated7 sites in 1 country100 target enrollmentStarted: February 1, 2008Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
100
Locations
7
Primary Endpoint
Primary Patency of the Treated Renal Artery

Study Overview

Brief Summary

The purpose of the study is to evaluate the safety and effectiveness of the Formula Balloon-Expandable Stent in treatment of renal artery stenosis.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •renal artery stenosis
  • •appropriate size and location of the lesion
  • •suboptimal angioplasty

Exclusion Criteria

  • •less than 18 years old
  • •failure or inability to give informed consent
  • •simultaneously participating in another drug or device study

Arms & Interventions

1

Experimental

renal artery stenting

Intervention: Formula Balloon-Expandable Stent (Device)

Outcomes

Primary Outcomes

Primary Patency of the Treated Renal Artery

Time Frame: 9 Months

Based on ultrasound images assessed by core lab.

Secondary Outcomes

  • 30-day Clinical Success(30 Days)
  • Number of Participants With 30-day Major Adverse Events(30 Days)
  • Number of Participants With 9-month Major Adverse Events(9 Months)
  • Technical Success(Prior to Discharge)
  • Acute Procedural Success(Prior to Discharge)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (7)

Loading locations...

Similar Trials